Skip to content

Safety and Efficacy of Lidocaine Infiltration in Suction Assisted Lipectomy

Safety and Efficacy of Lidocaine Infiltration in Suction Assisted Lipectomy With Tumescent Technique. A Randomized, Double Blinded, Controlled Trial.

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00591487
Enrollment
60
Registered
2008-01-11
Start date
2007-12-31
Completion date
Unknown
Last updated
2008-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

suction, assisted, lipectomy, liposuction, contour, cosmetic, plastic, surgery, Klein, tumescent, technique, Healthy women wanting Suction Assisted Lipectomy

Brief summary

RCT of S/E of lidocaine infiltration in tumescent technique.

Interventions

DRUGLidocaine

Subcutaneous infiltration with Active/Placebo solutions with tumescent technique previous to suction assisted lipectomy. Patient abdomen and back will be divided in 4 zones anterior and posterior, one side (left or right) will be infiltrated with active solution and the other with placebo. The allocation of the side will be made with random numbers.

Sponsors

Hospital Militar de Santiago
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Woman * I or II of the Classification of the American Society of Anesthesiologists. * Completed high school. * Between 18 and 40 years old * At least suction of entire abdomen and back * Body mass index between 20 and 27 * Accept written informed consent

Exclusion criteria

* Associated surgery * Hypersensibility to (Cefazolin or Clindamycin, Lidocaine, Ketorolac, Morphine, Remifentanyl, Propofol, Tramadol). * Pregnancy * Previous surgery to abdominal wall or back, including cesarean. * Abdominal wall hernia * Previous liposuction * Active psychosis

Design outcomes

Primary

MeasureTime frame
Pain (VSA)1, 6, 12, 18 and 24 post operative hours

Secondary

MeasureTime frame
Rescue medication1, 6, 12, 15 and 24 hours postoperative
Nausea, emesis, arrythmia, seizures, arrest, shock, death.24 hours postoperative

Countries

Chile

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026